MannKind Stock (NASDAQ: MNKD) stock price, news, charts, stock research, profile.
Open | $5.02 |
Close | $5.13 |
Volume / Avg. | 1.63M / 2.28M |
Day Range | 4.92 - 5.14 |
52 Wk Range | 3.17 - 5.75 |
Market Cap | $1.40B |
P/E Ratio | 125.75 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 13.3% |
Days to Cover | 15.1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of MannKind (NASDAQ:MNKD) through any online brokerage.
Other companies in MannKind’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Immatics (NASDAQ:IMTX), Arcutis Biotherapeutics (NASDAQ:ARQT), Day One Biopharmaceutical (NASDAQ:DAWN) and Xencor (NASDAQ:XNCR).
There is no analysis for MannKind.
MannKind has a consensus price target of $7.60.
The stock price for MannKind (NASDAQ: MNKD) is $5.15 last updated July 5, 2024 at 5:02 PM EDT.
There are no upcoming dividends for MannKind.
MannKind’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for MannKind.
MannKind is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.